[MigVax in Israel21C] In the race for a coronavirus vaccine, first doesn’t mean best

However, vaccine development, like drug development, is a long and complicated process. And it doesn’t always succeed, explains industry expert Ron Ellis, editor in chief of Human Vaccines & Immunotherapeutics and a consultant for Israeli vaccine development company MigVax.

Read more here.